Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Yttrium Radioisotopes. Found 6 abstracts

Narsinh KH, Van Buskirk M, Kennedy AS, Suhail M, Alsaikhan N, Hoh CK, Thurston K, Minocha J, Ball DS, Cohen SJ, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kanani S, Nutting CW, Moeslein FM, Savin MA, Schirm S, Putnam SG, Sharma NK, Wang EA, Rose SC. Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization. Radiology. 2017 Jan;282(1):281-8.   PMCID: PMC5207118
Carlier T, Willowson KP, Fourkal E, Bailey DL, Doss M, Conti M. (90)Y -PET imaging: Exploring limitations and accuracy under conditions of low counts and high random fraction. Med Phys. 2015 Jul;42(7):4295-309.
Willowson KP, Tapner M, The QI, Bailey DL, Willowson KP, Tapner MJ, Ahmadzadehfar H, Amthauer H, Großer OS, Arbizu J, Martí-Climent JM, Rodriguez-Fraile M, Attarwala AA, Glatting G, Molina-Duran F, Bagni O, Filippi L, Benard F, Celler A, Bonutti F, Botta F, Ferrari M, Boucek JA, Francis R, Bourgeois AC, Bradley YC, Pasciak AS, Buchholz HG, Miederer M, Büsing KA, Schönberg SO, Carlier T, Eugene T, Cervo M, Moore SC, Civollani S, Pettinato C, Conti M, Craig AJ, Flux GD, Cremonesi M, D’Andrea M, Iaccarino G, Strigari L, D’Arienzo M, D’Asseler Y, Lambert B, Di Martino F, Doss M, Duan H, Hoffmann M, Flamen P, Vanderlinden B, Fletcher AM, Fourkal E, Freeman LM, Geatti O, Goedicke A, Habito CM, Ouyang J, Hallam A, Morgan DG, Heard S, Leek F, Holm S, Mortensen J, de Nijs R, Hooker CA, Jeans SP, Julyan PJ, Kabasakal L, Tanyildizi H, Tanyildizi H, Kappadath SC, Siman W, Lassmann M, Schlögl S, Law MW, Lee VH, Ng SC, Lhommel R, Lodge MA, Luster M, McGowan DR, McLamb B, Kaiser HJ, Mottaghy FM, Mulder RU, Judy P, Stone JR, Lopez A, Munk OL, Staanum PF, Muzaffar R, Osman MM, Nijran KS, Towey DJ, O’Keefe GJ, Pooley RA, McKinney JM, Rausch IF, Reindl M, Sheikh A, Song N, Srinivas SM, Weir G, Yu N, Bailey DL. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study. European Journal of Nuclear Medicine and Molecular Imaging. 2015 Jul;42(8):1202-22.   PMCID: 4480824
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Borghaei H, Schilder RJ. Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Seminars in Nuclear Medicine. 2004 Jan;34(1 Suppl 1):4-9.
Borghaei H, Wallace SG, Schilder RJ. Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma. Clinical Lymphoma. 2004 Oct;5 Suppl 1:S16-21.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Yttrium Radioisotopes

Yttrium Radioisotopes rt [Radiotherapy] Radioimmunotherapy methods Imaging Phantoms 0 (Yttrium Radioisotopes) pd [Pharmacology] ae [Adverse Effects] Radiopharmaceuticals tu [Therapeutic Use] Positron-Emission Tomography Therapeutic Embolization X-Ray Computed Tomography Non-Hodgkin Lymphoma Treatment Outcome im [Immunology] Multimodal Imaging Monoclonal Antibodies Female Microspheres Prognosis mt [Methods] 0 (Immunotoxins) 2-diamine (N-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1 Monoclonal) 0 (Antibodies SCID Mice Retrospective Studies Magnetic Resonance Imaging Immunoglobulin Variable Region 0 (Isothiocyanates) instrumentation radiotherapy CD20 Antigens diagnostic imaging Arteriovenous Fistula Safety Human bi [Biosynthesis] Water Photons Tumor Cell Line Non-US Gov't Research Support Isothiocyanates Nude Mice Non-US Gov't Support Angiography pk [Pharmacokinetics] 67-43-6 (Pentetic Acid) Liver N' -N-N'-N''-N''-pentaacetic acid) ri [Radionuclide Imaging] Colorectal Neoplasms ad [Administration & Dosage] erbB-2 Receptor Immunotoxins Adult 0 (ibritumomab tiuxetan) Risk Factors erbB-2) EC 2-7-1-112 (Receptor complications Radiation Dosage 0 (Immunoglobulin Variable Region) Middle Aged aa [Analogs & Derivatives] Algorithms X-Ray Microtomography Adenocarcinoma Lung Male Xenograft Model Antitumor Assays Breast Neoplasms Aged Second Primary Neoplasms pathology 142434-84-2 Survival Rate therapeutic use Ovarian Neoplasms blood supply adverse effects Pentetic Acid Mice CD20) 0 (Antigens Tissue Distribution me [Metabolism]
Last updated on Wednesday, February 05, 2020